Approved Study Database

Ref. No. Scientific Title Principal investigator
2012.140 Effect of an innovative herbal supplementation on oxidative stress and muscle micro-damage after exercise in healthy males: a double-blinded corssover-designed experimental study Prof. Wong Heung-Sang Stephen
2012.138 Development of an automatic physical activity measuring and reporting system for online exercise promotion: the Virtual Trainer 3rd Version. Professor Hui Stanley Sai-chuen
2012.137 A pilot study on robotic laparoendoscopic single site cholecystectomy Prof. NG Enders Kwok Wai
2012.136 Evaluation of Morbidities, Endpoints and Reaching targets in Diabetic patients managed by an All-encompassing program Led by a Diabetes specialist team (EMERALD) Prof CHAN Chung Ngor Juliana
2012.134 A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTI-CENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ONCE-DAILY ADMINISTRATION OF A PHOSPHODIESTERASE 5 INHIBITOR (PF-00489791) IN ADULTS WITH TYPE 2 DIABETES AND OVERT NEPHROPATHY Dr Ozaki Risa
2012.133 A Randomized, Open Label, Multi-National Study of Cabazitaxel At 25 mg/m_ Every 3 Weeks in Combination With Prednisone Compared To Mitoxantrone in Combination With Prednisone in Asian Patients with Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen Dr HO Wing-Ming
2012.132 A prospective, double blind, randomised trial comparing nebulised sodium heparin versus placebo in ventilator associated pneumonia prevention (IPHIVAP study) Dr WAI KA MING
2012.129 A phase I open-label dose escalation study with expansion to assess the safety and tolerability of INC280 in patients with c-MET dependent advanced solid tumors Prof. MA Brigette Buig Yue
2012.118 Intensification of pre-operative therapy with multi-agent chemotherapy and concurrent chemoradiotherapy prior to total mesorectal excision surgery in patients with high risk rectal cancer Prof. MA Brigette
2012.109 A Phase III, multicentre, international, randomised, parallel group, double blind cardiovascular safety study of BI 10773 (10 mg and 25 mg administered orally once daily) compared to usual care in type 2 diabetes mellitus patients with increased cardiovascular risk Dr. TSANG Chiu Chi
2012.108 A Phase III, multicentre, international, randomised, parallel group, double blind cardiovascular safety study of BI 10773 (10 mg and 25 mg administered orally once daily) compared to usual care in type 2 diabetes mellitus patients with increased cardiovascular risk Dr. OZAKI Risa
2012.106 Myfortic (enteric-coated mycophenolate-sodium) for the treatment of non-infectious uveitis (anterior, intermediate or posterior uveitis). A prospective controlled randomized single center trial Dr. BRELÉN Mårten
2012.105 ADJUVANT AXITINIB TREATMENT OF RENAL CANCER: A RANDOMIZED DOUBLE-BLIND PHASE 3 STUDY OF ADJUVANT AXITINIB VS. PLACEBO IN SUBJECTS AT HIGH RISK OF RECURRENT RCC Prof. NG Chi Fai
2012.104 Autism Spectrum Disorder (ASD): A Local Study of its Clinical Profile, Parenting Stress and Intervention Strategies Ms. LAI Wing Yee Robby
2012.103 Multisensor Chronic Evaluations in Ambulatory Heart Failure Patients (MultiSENSE) Dr. Chan Yat Sun Joseph
2012.102 Clinical bioequivalence study on two amisulpride formulations Professor Lee Hon-leung, Vincent
2012.101 A Structured Nurse-led Clinic after Open Access Endoscopy for Patients with Functional Dyspepsia: A Randomized Controlled Study Dr. HUI Aric Josun
2012.099 Anti-inflammatory Effects of Macrolide Treatment in Influenza Lower Respiratory Tract Infections Prof. LEE Nelson
2012.096 Prospective comparative study on Endoscopic Ultrasonography (EUS) – Guided Fine-Needle Aspiration (FNA) using the 22G Conventional needles or Procore Needles without immediate on-site cytopathologic examination. Dr CHONG CHING NING
2012.095 Urgent vs. Early endoscopy in high risk patients with UGIB Prof. LAU James Yun Wong
2012.086 A Novel Pharmacological Treatment of Intermittent Claudication in Patients with Peripheral Arterial Disease: A Randomized Double-blind Placebo-control Trial of Traditional Chinese Medicine Salviae miltiorhizae(Danshen) and Puerariae lobatae (Gegen) Professor Yan Bryan Ping-Yen
2012.077 An Investigation into the Biology of Circulating Nucleic in Patients with Systemic Lupus Erythematosus by Next-Generation Sequencing Prof Lo Yuk Ming Dennis
2012.076 A randomized controlled study on the effects of CPAP on visceral fat thickness, carotid intima-media thickness and adipokines in patients with Obstructive Sleep Apnoea Syndrome Prof Hui Shu Cheong David
2012.059 A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Co-Administration of Sitagliptin and Atorvastatin in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin Monotherapy Dr. Tsang Chiu-Chi
2012.057 Dexamethasone ear drop with grommet placement versus intratympanic steroid injection for patient with sudden sensorineural hearing loss. A randomized prospective clinical trial. Dr. CHANG Wai Tsz
2012.056 Genomic sequencing in familial Adolescent Idiopathic Scoliosis Prof. TANG Nelson Leung Sang
2012.055 Wear Trial of Garment with Chinese Medicine for Treatment of Atopic Dermatitis Professor Hon Kam-Lun Ellis
2012.047 An Investigation of the Response of Keloid Scars to Corticosteroid and 5-Fluorouracil: Characterization of miRNA Expression, Histopathology and Clinical Features Professor Burd Andrew
2012.046 Serum hepatitis B surface antigen levels to guide the stopping of entecavir in HBeAg-negative chronic hepatitis B Prof Chan Lik Yuen Henry
2012.044 A Phase 1 Dose Escalation and Pharmacokinetic Study of Alisertib (MLN8237), an Aurora A Kinase Inhibitor, in Adult East Asian Patients With Advanced Solid Tumors or Lymphomas Dr. Ma Brigette Buig Yue
2012.034 An Open-label study to investigate Deep Brain Stimulation over ventral capsule/ventral striatum area in the treatment of Resistant Obsessive Compulsive Disorder Prof. POON Wai Sang
2012.022 Remote IscheMic Preconditioning in CArdiaC Surgery Trial Dr HO Anthony MH
2012.007 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis Prof. TAM Lai Shan
2011.621 A Randomized, Double-Blind, Placebo-Controlled Trial to Investigate Safety and Efficacy of Cerebrolysin in Patients with Traumatic Brain Injury Prof. POON Wai Sang
2011.619 Lifestyle intervention using an internet-based curriculum with cell phone reminders among obese Chinese adolescents: A randomized controlled pilot study Professor Nelson Edmund Anthony
2011.618 Blood microRNA expression profiling of aneurysmal subarachnoid hemorrhage (SAH) patients in relationship to Simvastatin Treatment Professor Wong Kwok Chu
2011.616 An Open Label, Pharmacogenetic study of Bisoprolol Treatment in Patients with Uncontrolled Essential Hypertension Professor Tomlinson Brian
2011.614 The effect of subdural drain placement after burr hole evacuation of chronic subdural haematomas on recurrence: a prospective randomised-controlled multi-centre study Mr. Woo Yat ming, Peter
2011.613 A Randomized Clinical Trial to Compare a Strategy Utilizing Genetic Testing and Personalized Risk Counselling with Standard Care on Patient Empowerment, Risk Factors Control and the Risk of Diabetic Complications Prof. MA Ronald Ching Wan
2011.610 A new test for on-field evaluation of hamstring strain risk Miss Li Cheng
2011.607 An Open-Label, Multicenter Evaluation of Safety, Pharmacokinetics, and Efficacy of Recombinant Coagulation Factor IX Fc Fusion Protein, BIIB029, in the Prevention and Treatment of Bleeding Episodes in Pediatric Subjects With Hemophilia B Dr. Li Chi Kong
2011.606 An Open-Label, Multicenter Evaluation of Safety, Pharmacokinetics, and Efficacy of Recombinant Coagulation Factor VIII Fc Fusion Protein, BIIB031, in the Prevention and Treatment of Bleeding Episodes in Pediatric Subjects With Hemophilia A Dr. Li Chi Kong
2011.605 A 5-year study to compare the durability of glycemic control of a combination regimen with vildagliptin & metformin versus standard-of-care monotherapy with metformin, initiated in treatment-naïve patients with type 2 diabetes mellitus Dr. TSANG Chiu Chi
2011.604 A 5-year study to compare the durability of glycemic control of a combination regimen with vildagliptin & metformin versus standard-of-care monotherapy with metformin, initiated in treatment-naïve patients with type 2 diabetes mellitus Dr. OZAKI Risa
2011.603 A PHASE III STUDY OF POSTOPERATIVE RADIATION THERAPY (IMRT) +/- CETUXIMAB FOR LOCALLY-ADVANCED RESECTED HEAD AND NECK CANCER Dr. POON Darren Ming Chun
2011.602 A Phase III Randomised, Double blind, Placebo controlled, Parallel, Multicentre Study to Assess the Efficacy and Safety of continuing IRESSATM 250 mg in addition to Chemotherapy versus Chemotherapy alone in Patients who have Epidermal Growth Factor Receptor (EGFR) Mutation Positive Locally advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) and have progressed on First Line IRESSATM. IMPRESS- (IRESSATM Mutation Positive Multicentre Treatment Beyond ProgRESsion Study) Prof. MOK Tony
2011.600 Randomized Control Trial on lifestyle modification program for people with metabolic syndrome Ms. LAU KAM HA
2011.599 An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects with Crohn Dr Ng Siew Chien
2011.598 A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission with GSK1605786A in Subjects with Moderately-to-Severely Active Crohn Dr Ng Siew Chien
2011.597 A 52 week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects with Crohn's Disease Dr Ng Siew Chien

Page 231 of 263.